Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: Results of a prospective study

Obesity

Volumn 24, Issue 9, 2016, Pages 1849-1853

  Gómez, Victoria ^a   Woodman, George ^b   Abu Dayyeh, Barham K ^c  

^a MAYO CLINIC   (United States)

^b Midsouth Bariatrics   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIOR CHANGE; BEHAVIOR MODIFICATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DELAYED STOMACH EMPTYING; DEVICE REMOVAL; DEVICE SAFETY; DEVICE THERAPY; DIGESTIVE TRACT PARAMETERS; FEMALE; GASTRIC BALLOON; GASTRIC RETENTION; HUMAN; KINESIOTHERAPY; LIFESTYLE MODIFICATION; LOW CALORY DIET; MALE; MULTICENTER STUDY; OBESITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; STOMACH MOTILITY; THERAPY EFFECT; TREATMENT DURATION; WEIGHT REDUCTION;

EID: 84983749106     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21555     Document Type: Article

References (11)

1. Acosta A, Camilleri M, Burton D, et al. Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study. Physiol Rep 2015;3. doi: 10.14814/phy2.12610.
2. Centers for Disease Control and Prevention (CDC). Overweight and obesity. Available at: http://www.cdc.gov/obesity/data/index.html. Accessed September 1, 2015.
3. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224–2260.
4. Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009;9:88.
5. Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 2015;82:425–438.
6. Acosta A, Camilleri M, Shin A, et al. Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy. Gastroenterology 2015;148:537–546.
7. Delgado-Aros S, Camilleri M, Castillo EJ, et al. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study. Clin Gastroenterol Hepatol 2005;3:997–1006.
8. Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 2011;365:1597–1604.
9. Mathus-Vliegen EM, Eichenberger RI. Fasting and meal-suppressed ghrelin levels before and after intragastric balloons and balloon-induced weight loss. Obes Surg 2014;24:85–94.
10. Mion F, Napoleon B, Roman S, et al. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients. Obes Surg 2005;15:510–516.
11. Su HJ, Kao CH, Chen WC, Chang TT, Lin CY. Effect of intragastric balloon on gastric emptying time in humans for weight control. Clin Nucl Med 2013;38:863–868.